Green analytical chemistry and quality by design: A combined approach towards simultaneous determination of Letrozole with its co-administered Zoledronic Acid for cancer patients
Date
2024-08-01
Journal Title
Journal ISSN
Volume Title
Type
Article
Publisher
Elsevier B.V
Series Info
Journal of Pharmaceutical and Biomedical Analysis ; Volume 4 , December 2024 Article number 100036
Scientific Journal Rankings
Abstract
Nowadays, breast cancer is the most affecting and globally diagnosed malignancy among women, yet Letrozole
(LTZ) was considered the first-line treatment as hormonal anticancer drug. Unfortunately, LTZ develops osteoporosis as a main side effect which was overcome by using the co-administered; Zoledronic Acid (ZDA). Thus,
there was a crucial need for this simultaneous quantification innovation, especially there were no any previously
reported methods regarding both drugs together. In this study, an integrated framework was conducted between
the experimental analytical quality-by-design (AQbD) approach and green analytical chemistry (GAC), emerging
sensitive and robust RP-HPLC method. Box-Behnken Design was the developed model for optimizing an isocratic
chromatographic separation on C18 Equisil® ODS (4.6 × 250 mm, 5.0 μm) column at ambient temperature, using
the mobile phase of 0.1 % aqueous trifluroacetic acid (pH 2.8): acetonitrile (54.5:45.5, v/v), at 1.0 mL/min flow
rate with PDA detection at 254.0 nm and 210.0 nm for LTZ and ZDA, respectively. Model statistical and residual
plots analysis was significant and normally distributed. Method was fully validated as per ICH guidelines, where
good linearity was 0.20–10.00 µg/mL for both drugs in presence of Tadalafil (TDF) as an internal standard,
obtaining adequate correlation coefficients (r) values. Calculated LOD results were 0.058 and 0.040 µg/mL while
calculated LOQ results were 0.175 and 0.122 µg/mL for LTZ and ZDA, respectively. The proposed method was
effectively applied on bulk, pharmaceutical dosage forms, and spiked human plasma. Statistical comparison of
the anticipated results with the reported ones was performed. Greenness assessment was evaluated using Green
Analytical Procedure Index (GAPI) and Analytical Greenness (AGREE) tools; where superiority results were
achieved relative to other reported methods. Finally, an EVG method evaluation tool was assessed, and the
attained results were represented through its radar chart.
Description
Keywords
Green Profile, HPLC, Letrozole, Quality by design, Spiked plasma, Zoledronic Acid
Citation
El-Fatah, N. a. A., Elbalkiny, H. T., Hegazy, M. A., Fouad, M. M., & El-Sayed, G. M. (2024). Green analytical chemistry and quality by design: A combined approach towards simultaneous determination of Letrozole with its co-administered Zoledronic Acid for cancer patients. Journal of Pharmaceutical and Biomedical Analysis Open, 4, 100036. https://doi.org/10.1016/j.jpbao.2024.100036